A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia
Status:
Completed
Trial end date:
2010-10-02
Target enrollment:
Participant gender:
Summary
This Phase 1, double-blind (sponsor open) study will assess the safety, tolerability,
pharmacokinetics and pharmacodynamics of multiple doses of ETC-1002 given to subjects with
mild dyslipidemia.